1Barnes PJ, Godfrey S. Asthma therapy [ M ]. Lomkm: Martin Dunitz, 1998.1 --22.
2Umland SP, Schleimer RP, Johnston SL. Review of the molecular and cellular mechanisms of action of glueocortieoids for use in asthma [ J ]. Pulm Pharacol Therapeutic, 2002,15 : 35-- 50.
3Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids [J ]. Am J Respir Crit Care Med, 1998,157: S1 $53.
4Ogryzko VV, Sehiltz RL, Russanova V, et al. The transcriptional co-activators p300 and CBP are histone acetyltransferases [J]. Cell, 1996,87 : 953 -- 959.
5Imhof A, Wolffe AP. Transcription: gene control by targeted histone acetylation[ J ]. Curr Biol, 1998,8: R422-- R424.
6Itok M, Barmes P J, Adcock IM. Glucocorticoid receptor recruitment of histone deacetylase 2 inhibits IL-β induced histone H4 acetylation on lysines 8 and 12[J]. Mol Cell Biol ,2000,20:6891-6903.
7Barnes PJ. Scientific rational for inhaled combination therapy with long-acting β2-agonists and certicosteroids [J ]. Eur Respir J, 2002,19 : 182-191.
8Eickelberg O, Roth M, Lorx R, et al. Ligand-independent activation of the certicosteroid receptor by beta 2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells [J].J Biol Chem,1999,2n4:1005--1010.
9Pang L, Knox AS. Synergistic inhibition beta 2-agonists and corticpsleroid on tumor necrosis factor-α-induced interleukin-s release from cultured human airway smooth-muscle cells [ J ]. Am J Respir Cell Mol Biol, 2002,23 : 79 -- 85.
10Greening AP, Ind PW, Northfield M, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid [ J ]. Lancet, 1994, 344:219 --224.
